Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Expectations too high. Reset your animus.

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Oct 13, 2022 10:30am

168 Views

Post# 35022131

RE:RE:RE:RE:RE:RE:Expectations too high. Reset your animus.

You are porbably right about that but we will pay the price once again as shareholders. Luckey they don't need money but come May 2023 AGM it's game over for those guys if were at 1 or 2$ whatever the next 3 months has in store then and there.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?